Your browser doesn't support javascript.
loading
Research progress of porcine epidemic diarrhea virus S protein.
Luo, Haojian; Liang, Zhaoping; Lin, Junjie; Wang, Yiqiao; Liu, Yingying; Mei, Kun; Zhao, Mengmeng; Huang, Shujian.
Afiliação
  • Luo H; School of Life Science and Engineering, Foshan University, Foshan, China.
  • Liang Z; College of Veterinary Medicine, South China Agricultural University, Guangzhou, China.
  • Lin J; School of Life Science and Engineering, Foshan University, Foshan, China.
  • Wang Y; School of Life Science and Engineering, Foshan University, Foshan, China.
  • Liu Y; School of Life Science and Engineering, Foshan University, Foshan, China.
  • Mei K; School of Life Science and Engineering, Foshan University, Foshan, China.
  • Zhao M; School of Life Science and Engineering, Foshan University, Foshan, China.
  • Huang S; School of Life Science and Engineering, Foshan University, Foshan, China.
Front Microbiol ; 15: 1396894, 2024.
Article em En | MEDLINE | ID: mdl-38873162
ABSTRACT
Porcine epidemic diarrhea virus (PEDV) is a single-stranded RNA virus with a capsid membrane that causes acute infectious gastrointestinal disease characterized by vomiting, diarrhea, and dehydration in swine. Piglets are more susceptible to PEDV than adults, with an infection rate reaching 90% and a fatality rate as high as 100%. Moreover, PEDV has a rapid transmission rate and broad transmission range. Consequently, PEDV has caused considerable economic losses and negatively impacted the sustainability of the pig industry. The surface spike (S) glycoprotein is the largest structural protein in PEDV virions and is closely associated with host cell fusion and virus invasion. As such, the S protein is an important target for vaccine development. In this article, we review the genetic variation, immunity, apoptosis-induction function, virulence, vaccine potential, and other aspects of the PEDV S protein. This review provides a theoretical foundation for preventing and controlling PEDV infection and serves as a valuable resource for further research and development of PEDV vaccines.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article